Literature DB >> 11342482

The search for replacements for unfractionated heparin.

E M Antman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342482     DOI: 10.1161/01.cir.103.18.2310

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Promise of factor Xa inhibition in acute coronary syndromes.

Authors:  Leong Lee; Derek Chew
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 2.  The management of thrombotic lesions in the cardiac catheterization laboratory.

Authors:  Fadi Matar; Jad Mroue
Journal:  J Cardiovasc Transl Res       Date:  2011-10-21       Impact factor: 4.132

3.  Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.

Authors:  Malak El-Rayes; Erick Schampaert; Jean-Claude Tardif; Mark Jeffrey Eisenberg; Marc Afilalo; Simon Kouz; Claude Lauzon; Richard Harvey; Michel Nguyen; Remi Kouz; Jean-Pierre Dery; Samer Mansour; Anne-Marie Van Kieu; Stephane Rinfret; Thao Huynh
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

Review 4.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

5.  Efficacy and safety of a new streptokinase regimen with enoxaparin in acute myocardial infarction.

Authors:  Gabriel Tatu-Chitoiu; Cristina Teodorescu; Monica Dan; Petre Capraru; Manuela Guran; Oana Istratescu; Alexandrina Tatu-Chitoiu; Aurelia Bumbu; Maria Dorobantu
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

6.  Clinician update: direct thrombin inhibitors in acute coronary syndromes.

Authors:  Joanna J Wykrzykowska; Sekar Kathiresan; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

7.  ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy.

Authors:  Deepak Thomas; Robert P Giugliano
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

8.  Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction.

Authors:  Ali Maleki; Arman Shariari; Masoumeh Sadeghi; Negin Rashidi; Farshid Alyari; Saeid Forughi; Behjat Nabatchi; Reza Ghanavati
Journal:  ARYA Atheroscler       Date:  2012

Review 9.  Utilizing enoxaparin in the management of STEMI.

Authors:  Andrea Rubboli; Alessandro Capecchi; Giuseppe Di Pasquale
Journal:  Vasc Health Risk Manag       Date:  2007

Review 10.  New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications.

Authors:  Conor J McCann; Ian B A Menown
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.